Devices › Intervertebral fusion device with bone graft, lumbar
Device brand name · Intervertebral fusion device with bone graft lumbar
Clydesdale Spinal System: medical device reports filed with FDA
260 reports name it, 2013–2026. Manufacturer given most often on reports: Msd Deggendorf Mfg. Product code MAX.
- 260
- device reports naming the brand
- 0% of all MAUDE reports · about 19 a year
- 33
- reports, 12 months to August 2026
- 18 in the 12 months before
- 53.1%
- classified as malfunction
- 63.3% across the product code
- 0.4%
- classified as death, as reported
- 1 reports · not verified by FDA
FDA's MAUDE database holds 260 reports that name the brand "Clydesdale Spinal System" (intervertebral fusion device with bone graft lumbar), received between January 2013 and August 2026; the manufacturer given most often on reports is Msd Deggendorf Mfg. Spellings of one product vary from report to report.
33 reports arrived in the 12 months to August 2026, up 83% from 18 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (53.1%), injury (46.2%) and death (0.4%); across all intervertebral fusion device with bone graft, lumbar reports (product code MAX) death is recorded in 0.3% and malfunction in 63.3%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are break (29.2%), migration or expulsion of device (9.6%) and migration (5%). The patient problems coded most often are injury, pain and bone fracture(s). FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 9,238 reports carrying product code MAX. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Breakthe device broke | 76 | 29.2% | 28.7% |
| Migration or expulsion of device | 25 | 9.6% | 6.8% |
| Migrationthe device moved from where it was placed | 13 | 5% | 8.5% |
| Malposition of device | 5 | 1.9% | 1.3% |
| Mechanics altered | 5 | 1.9% | 1.3% |
| Detachment of device component | 3 | 1.2% | 1.4% |
| Device dislodged or dislocated | 3 | 1.2% | 2.1% |
| Unintended movement | 3 | 1.2% | 0.8% |
| Crackthe device cracked | 2 | 0.8% | 1.4% |
| Degraded | 2 | 0.8% | 0% |
| Difficult to removethe device was hard to remove | 2 | 0.8% | 0.7% |
| Mechanical problema mechanical problem | 2 | 0.8% | 5.7% |
| Collapse | 1 | 0.4% | 2.3% |
| Cut in material | 1 | 0.4% | 0% |
| Detachment of device or device componentpart of the device came off | 1 | 0.4% | 1.1% |
| Difficult to insertthe device was hard to insert | 1 | 0.4% | 1.3% |
| Fracturea broken bone | 1 | 0.4% | 8.5% |
| Insufficient device problem information | 1 | 0.4% | 2% |
| Loose or intermittent connection | 1 | 0.4% | 0.8% |
| Loosening of implant not related to bone-ingrowth | 1 | 0.4% | 0.3% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Injurya physical injury | 24 | 9.2% |
| Painpain, site not specified | 17 | 6.5% |
| Bone fracture(s) | 8 | 3.1% |
| Numbnessnumbness | 8 | 3.1% |
| Device embedded in tissue or plaque | 6 | 2.3% |
| Hematomaa collection of blood under the skin or in tissue | 6 | 2.3% |
| Neuropathy | 6 | 2.3% |
| Appropriate clinical signs, symptoms and conditions term/code not available | 3 | 1.2% |
| Spinal column injury | 3 | 1.2% |
| Deaththe patient died; cause not stated by this term | 2 | 0.8% |
| Muscle weakness/atrophy | 2 | 0.8% |
| Nerve damage | 2 | 0.8% |
| Neurological deficit/dysfunction | 2 | 0.8% |
| Post operative wound infection | 2 | 0.8% |
| Stenosis | 2 | 0.8% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Clydesdale Spinal System | Product code MAX | All MAUDE reports |
|---|---|---|---|
| Reports | 260 | 9,238 | 26,136,888 |
| Share of that pool | — | 2.8% | 0% |
| Classified as death, per 1,000 reports | 4 | 3 | 9 |
| Classified as injury | 46.2% | 35.6% | 36.2% |
| Classified as malfunction | 53.1% | 63.3% | 62.3% |
| Filed by the manufacturer | 99.6% | 97.1% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code MAX
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Catalyft PL Expandable Interbody System | 378 | 95 | 0% |
| ELEVATE Spinal System | 386 | 46 | 0% |
| CAPSTONE Spinal System | 358 | 26 | 0.3% |
| Crescent Spinal System | 322 | 5 | 0.6% |
| CLYDESDALE PTC Spinal System | 222 | 5 | 0% |
| Pivox Oblique Lateral Spinal System | 255 | 5 | 0% |
| T-Pal Spacer Applicator Inner Shaft | 271 | 0 | 0% |
| T-Pal Spacer Applicator Knob | 185 | 0 | 0% |
| T-Pal Spacer Applicator Handle | 157 | 0 | 0% |
| Unknown Cage/Spacer | 280 | 4 | 0% |
| Unknown_Spine_Product | 596 | 24 | 0% |
| Orthopedic Manual Surgical Instrument | 1,143 | 0 | 0.2% |
| Collect No Qas Spine Anterior Stabilis | 269 | 0 | 0% |
| Verte-Stack Spinal System | 212 | 0 | 0.5% |
| Divergence Anterior Cervical Fusion System | 230 | 30 | 0% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Clydesdale Spinal System reports
How many FDA reports name Clydesdale Spinal System?
260 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 33 in the latest 12 months.
What kinds of events are reported?
malfunction (53.1%), injury (46.2%) and death (0.4%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
break (29.2%), migration or expulsion of device (9.6%), migration (5%), malposition of device (1.9%) and mechanics altered (1.9%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (99.6%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Clydesdale Spinal System was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.